LSE - Delayed Quote GBp
MaxCyte, Inc. (MXCT.L)
212.20
-2.80
(-1.30%)
As of 8:26:19 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 5 | 6 |
| Avg. Estimate | -0.1 | -0.09 | -0.34 | -0.31 |
| Low Estimate | -0.12 | -0.1 | -0.36 | -0.35 |
| High Estimate | -0.09 | -0.09 | -0.33 | -0.22 |
| Year Ago EPS | -0.09 | -0.09 | -0.39 | -0.34 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 7 |
| Avg. Estimate | 9.05M | 9.77M | 41.38M | 52.84M |
| Low Estimate | 7.78M | 9.25M | 40.28M | 47M |
| High Estimate | 9.9M | 10.5M | 42.1M | 72.07M |
| Year Ago Sales | 11.34M | 10.43M | 38.63M | 41.38M |
| Sales Growth (year/est) | -20.20% | -6.32% | 7.14% | 27.68% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.12 | -0.13 | -0.12 | -0.12 |
| EPS Actual | -0.09 | -0.09 | -0.11 | -0.1 |
| Difference | 0.03 | 0.04 | 0.01 | 0.02 |
| Surprise % | 27.42% | 29.69% | 11.29% | 18.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.09 | -0.34 | -0.31 |
| 7 Days Ago | -0.11 | -0.09 | -0.34 | -0.3 |
| 30 Days Ago | -0.11 | -0.11 | -0.34 | -0.31 |
| 60 Days Ago | -0.12 | -0.1 | -0.38 | -0.26 |
| 90 Days Ago | -0.12 | -0.1 | -0.37 | -0.27 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | -- | 1 | 1 | 1 |
| Down Last 30 Days | -- | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MXCT.L | -13.89% | -3.70% | 11.83% | 11.27% |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 3/12/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 4/23/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/13/2024 |
| Maintains | BTIG: Buy to Buy | 3/13/2024 |
| Initiated | Craig-Hallum: Buy | 11/29/2023 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 10/5/2023 |
Related Tickers
EKF.L EKF Diagnostics Holdings plc
21.70
+5.85%
CTKB Cytek Biosciences, Inc.
3.8600
+2.39%
OWLT Owlet, Inc.
3.9400
+4.51%
SN.L Smith & Nephew plc
995.60
-0.24%
UFPT UFP Technologies, Inc.
209.80
+1.45%
CODX Co-Diagnostics, Inc.
0.3711
+6.06%
BRKR Bruker Corporation
39.66
+1.51%
BIO Bio-Rad Laboratories, Inc.
240.17
-1.01%
RBOT Vicarious Surgical Inc.
8.46
-0.12%
QSI Quantum-Si incorporated
1.2100
-1.63%